Plasmid News and Research

RSS
World's deadliest malaria parasite cloaking gene revealed

World's deadliest malaria parasite cloaking gene revealed

Artificial mammalian origin of replication

Artificial mammalian origin of replication

New way to generate genetically altered influenza virus

New way to generate genetically altered influenza virus

Gene therapy may prevent the damaging effects of radiation

Gene therapy may prevent the damaging effects of radiation

Deadly 1918 Spanish flue virus has been reconstructed and characterized

Deadly 1918 Spanish flue virus has been reconstructed and characterized

Vical receives $12 Million HIV vaccine order

Vical receives $12 Million HIV vaccine order

FDA grants Vical orphan-drug designation

FDA grants Vical orphan-drug designation

New approach to inhibiting blood vessel growth or angiogenesis

New approach to inhibiting blood vessel growth or angiogenesis

Artificial cobweb proteins for medicine

Artificial cobweb proteins for medicine

Nephrogenic Syndrome of Inappropriate Antidiuresis - a new genetic disease

Nephrogenic Syndrome of Inappropriate Antidiuresis - a new genetic disease

Experimental vaccine targeting West Nile virus

Experimental vaccine targeting West Nile virus

Gene therapy shows effect in heart patients

Gene therapy shows effect in heart patients

Promising new therapy that prompts the immune system to aid in the fight against melanoma tumors

Promising new therapy that prompts the immune system to aid in the fight against melanoma tumors

Vical Incorporated issued two Canadian patents

Vical Incorporated issued two Canadian patents

EuroVacc 02 HIV Vaccine trial begins

EuroVacc 02 HIV Vaccine trial begins

Gene therapy for heart patients with chest pains who do not benefit from other treatments

Gene therapy for heart patients with chest pains who do not benefit from other treatments

Scientists have given blind nerve cells the ability to detect light

Scientists have given blind nerve cells the ability to detect light

Benitec receives exclusive rights to use DNA technology pioneered at Stanford University for all RNAi therapeutic uses

Benitec receives exclusive rights to use DNA technology pioneered at Stanford University for all RNAi therapeutic uses

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas

Study presents multiple lines of evidence against the proposed link between SV40 and human mesotheliomas